Table. Bloodstream infections caused by meticillin-resistant (n = 96,918) and meticillin-susceptible Staphylococcus aureus (n = 477,033), number of reporting laboratories and countries, EU/EEA, 2005–2018.
| Year | Countries | Laboratories | Staphylococcus aureus BSI | |||||
|---|---|---|---|---|---|---|---|---|
| Total | MRSA | MSSA | ||||||
| n | n | n | n | Crude % | Population-weighted % | n | ||
| All laboratories (dataset A) | ||||||||
| 2005 | 29 | 664 | 27,125 | 6,615 | 24.4 | 28.6 | 20,510 | |
| 2006 | 29 | 650 | 28,287 | 6,551 | 23.2 | 27.3 | 21,736 | |
| 2007 | 29 | 643 | 30,027 | 6,605 | 22.0 | 23.6 | 23,422 | |
| 2008 | 29 | 637 | 29,339 | 5,981 | 20.4 | 23.5 | 23,358 | |
| 2009 | 28 | 643 | 30,729 | 5,969 | 19.4 | 23.5 | 24,760 | |
| 2010 | 29 | 673 | 32,961 | 6,149 | 18.7 | 22.6 | 26,812 | |
| 2011 | 30 | 685 | 35,712 | 5,863 | 16.4 | 21.8 | 29,849 | |
| 2012 | 30 | 714 | 36,988 | 6,019 | 16.3 | 21.5 | 30,969 | |
| 2013 | 30 | 725 | 40,968 | 6,673 | 16.3 | 20.5 | 34,295 | |
| 2014 | 30 | 714 | 40,906 | 6,545 | 16.0 | 19.6 | 34,361 | |
| 2015 | 30 | 738 | 45,509 | 7,313 | 16.1 | 19.0 | 38,196 | |
| 2016 | 30 | 805 | 57,387 | 8,005 | 13.9 | 17.7 | 49,382 | |
| 2017 | 30 | 853 | 65,928 | 8,500 | 12.9 | 16.8 | 57,428 | |
| 2018 | 30 | 884 | 72,085 | 10,130 | 14.1 | 16.4 | 61,955 | |
| Laboratories that consistently reported data (dataset B) | ||||||||
| 2005 | 25 | 285 | 15,192 | 3,570 | 23.5 | 30.2 | 11,622 | |
| 2006 | 25 | 285 | 15,954 | 3,617 | 22.7 | 28.8 | 12,337 | |
| 2007 | 25 | 285 | 16,761 | 3,787 | 22.6 | 25.6 | 12,974 | |
| 2008 | 25 | 285 | 16,307 | 3,253 | 19.9 | 24.1 | 13,054 | |
| 2009 | 25 | 285 | 16,232 | 3,069 | 18.9 | 25.1 | 13,163 | |
| 2010 | 25 | 285 | 15,987 | 2,868 | 17.9 | 23.0 | 13,119 | |
| 2011 | 25 | 285 | 17,229 | 2,673 | 15.5 | 20.7 | 14,556 | |
| 2012 | 25 | 285 | 17,622 | 2,740 | 15.5 | 22.8 | 14,882 | |
| 2013 | 25 | 285 | 19,507 | 2,587 | 13.3 | 20.0 | 16,920 | |
| 2014 | 25 | 285 | 18,833 | 2,573 | 13.7 | 20.3 | 16,260 | |
| 2015 | 25 | 285 | 20,432 | 2,692 | 13.2 | 18.9 | 17,740 | |
| 2016 | 25 | 285 | 21,711 | 2,547 | 11.7 | 17.6 | 19,164 | |
| 2017 | 25 | 285 | 22,802 | 2,577 | 11.3 | 17.0 | 20,225 | |
| 2018 | 25 | 285 | 23,879 | 2,480 | 10.4 | 16.3 | 21,399 | |
BSI: bloodstream infections; EEA: European Economic Area; EU: European Union; MRSA: meticillin-resistant Staphylococcus aureus; MSSA: meticillin-susceptible S. aureus.
Results from all laboratories, 30 EU/EEA countries (dataset A) and from laboratories in 25 EU/EEA countries, which consistently reported data during the study period (dataset B).